United States · FDA National Drug Code directory
Nymyo
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51862-645_0048909e-ca81-45c9-9f5c-c5891f9bc85e
- Product NDC
- 51862-645
- Form
- KIT
- Composition / generic term
- norgestimate and ethinyl estradiol
- Labeler
- Mayne Pharma Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201011
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 PACKET (51862-645-01) / 1 KIT in 1 BLISTER PACK · 51862-645-01
- 1 BLISTER PACK in 1 CARTON (51862-645-02) / 1 KIT in 1 BLISTER PACK · 51862-645-02
- 3 BLISTER PACK in 1 CARTON (51862-645-03) / 1 KIT in 1 BLISTER PACK · 51862-645-03
- 6 BLISTER PACK in 1 CARTON (51862-645-06) / 1 KIT in 1 BLISTER PACK · 51862-645-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →